Registration number:
Gastro Medicine UK Ltd
for the Year Ended 30 April 2025
Gastro Medicine UK Ltd
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Gastro Medicine UK Ltd
Company Information
|
Director |
D Watts |
|
Registered office |
|
|
Accountants |
|
Gastro Medicine UK Ltd
(Registration number: SC434463)
Balance Sheet as at 30 April 2025
|
Note |
2025 |
2024 |
|
|
Current assets |
|||
|
Debtors |
|
|
|
|
Cash at bank and in hand |
|
|
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
( |
|
|
Net assets |
|
|
|
|
Capital and reserves |
|||
|
Called up share capital |
100 |
100 |
|
|
Retained earnings |
593,763 |
496,074 |
|
|
Shareholders' funds |
593,863 |
496,174 |
For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
|
• |
|
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
|
......................................... |
Gastro Medicine UK Ltd
Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025
|
General information |
The company is a private company limited by share capital, incorporated in Scotland.
The address of its registered office is:
These financial statements were authorised for issue by the
|
Accounting policies |
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Revenue recognition
Turnover comprises the invoiced value of goods and services supplied by the company, net of VAT and trade discounts. Turnover is recognised on the accruals basis.
Tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Gastro Medicine UK Ltd
Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Financial instruments
Classification
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
|
Staff numbers |
The average number of persons employed by the company (including the director) during the year, was
|
Debtors |
|
Current |
2025 |
2024 |
|
Trade debtors |
|
|
|
Other debtors |
|
|
|
|
|
Gastro Medicine UK Ltd
Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025
|
Creditors |
Creditors: amounts falling due within one year
|
2025 |
2024 |
|
|
Taxation and social security |
|
|
|
Accruals and deferred income |
|
|
|
Other creditors |
|
|
|
|
|
|
Share capital |
Allotted, called up and fully paid shares
|
2025 |
2024 |
|||
|
No. |
£ |
No. |
£ |
|
|
A Ordinary of £1 each |
60 |
60 |
60 |
60 |
|
B Ordinary of £1 each |
15 |
15 |
15 |
15 |
|
C Ordinary of £1 each |
5 |
5 |
5 |
5 |
|
D Ordinary of £1 each |
5 |
5 |
5 |
5 |
|
E Ordinary of £1 each |
5 |
5 |
5 |
5 |
|
F Ordinary of £1 each |
10 |
10 |
10 |
10 |
|
|
|
|
|
|
|
Related party transactions |
Key management personnel
At the balance sheet date, David Watts was due the company £422,240 (2024 - £278,710).
Interest was charged on the loan at a rate of 2.25% until 5 April 2025, after which the rate increased to 3.75%. Advances totalling £135,142 and payments totalling £500 were made during the year. The loan is unsecured and repayable on demand.